Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.
Vascular diseases are multifactorial, often requiring multiple challenges, or 'hits', for their initiation. Intra-vascular hemolysis illustrates well the multiple-hit theory where a first event lyses red blood cells, releasing hemolysis-derived products, in particular cell-free heme which is highly toxic for the endothelium. Physiologically, hemolysis derived-products are rapidly neutralized by numerous defense systems, including haptoglobin and hemopexin which scavenge hemoglobin and heme, respectively. Likewise, cellular defense mechanisms are involved, including heme-oxygenase 1 upregulation which metabolizes heme. However, in cases of intra-vascular hemolysis, those systems are overwhelmed. Heme exerts toxic effects by acting as a damage-associated molecular pattern and promoting, together with hemoglobin, nitric oxide scavenging and ROS production. In addition, it activates the complement and the coagulation systems. Together, these processes lead to endothelial cell injury which triggers pro-thrombotic and pro-inflammatory phenotypes. Moreover, among endothelial cells, glomerular ones display a particular susceptibility explained by a weaker capacity to counteract hemolysis injury. In this review, we illustrate the 'multiple-hit' theory through the example of intra-vascular hemolysis, with a particular focus on cell-free heme, and we advance hypotheses explaining the glomerular susceptibility observed in hemolytic diseases. Finally, we describe therapeutic options for reducing endothelial injury in hemolytic diseases.
['Frimat|Marie|M|', 'Boudhabhay|Idris|I|', 'Roumenina|Lubka T|LT|']
D000818:Animals D004730:Endothelium, Vascular D004912:Erythrocytes D006418:Heme D006454:Hemoglobins D006461:Hemolysis D006801:Humans
heme endothelial cells hemolytic diseases damage-associated molecular patterns (DAMPs) glomerular endothelium two-stage model disease